What is GSS.AX's gross margin?

Genetic (GSS.AX) has a gross margin of -106% and a net margin of -132%.

What is GSS.AX's P/E ratio?

Track Genetic (GSS.AX) P/E ratio, ROE, and valuation metrics over time.

Where can I see GSS.AX's full financials?

See Genetic (GSS.AX) income statement, cash flow, and balance sheet — quarterly and annual — alongside insider trading activity.

Genetic (GSS.AX) Financials — Revenue, Earnings, Cash Flow

A$0.08 ($0.05)

+0.00 (+0.00%)

Weekly Expected Move ±11.7%

A$0 A$0 A$0 A$0 A$0

ASX · Healthcare · Medical - Diagnostics & Research · Tech Score Neutral · Power 45 · A$17.9M mcap · 152M float · 0.345% daily turnover

Overview Chart Financials Income Statement Cash Flow Balance Sheet Earnings

Analysis Technicals Weather Peers

📊 Key Metrics

TTM

A$30M

Revenue

+13.7% YoY

A$-34M

Net Income

-6.9% YoY

A$-22M

Free Cash Flow

+38.6% YoY

-105.9%

Gross Margin

-154.2%

Op. Margin

-132.4%

Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

⚠️ Cash Burn Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE-70.5%

ROA-64.5%

ROIC-190.7%

Valuation

P/E-1.3

P/B0.5

EV/EBITDA0.2

Leverage

Debt/Equity0.01

Current Ratio13.10

Interest Cov.-261.2x

Quality Scores

Piotroski F5/9

Altman Z-1.60

Beneish M-4.23